Defining Resistant Diabetes
Hanford Yau, MD, Ralph DeFronzo, MD, Pam Kushner, MD, Honey East, MD, and Christopher Lucci, MD, explore resistant diabetes, share their clinical experience regarding the frequency of this condition, and highlight the role of continuous glucose monitoring in identifying patients who may be resistant, as indicated by prolonged periods of blood glucose levels outside the target range.
Now Viewing
EP: 1.Defining Resistant Diabetes
EP: 2.Differentiating Medication Non-Adherence From Underlying Comorbidities
EP: 3.Barriers to Accessing New Anti-Diabetes Medications
EP: 4.Suspecting Hypercortisolism in Patients With Resistant Diabetes
EP: 5.Testing for Hypercortisolism
EP: 6.Patient Subgroups With a Higher Prevalence of Hypercortisolism
EP: 7.Evolving Perception of Autonomous Adrenal Hypercortisolism
EP: 8.Pathophysiology of Hypercortisolism
EP: 9.Need to Address Underlying Hypercortisolism
EP: 10.Approaching Treatment in Hypercortisolism
EP: 11.Choosing Between Medical and Surgical Options for Hypercortisolism
EP: 12.Long-Term Outcomes for Patients Treated for Hypercortisolism
Recent Videos
Related Content
